SCHEDULE: Farallon Capital Discloses GRAIL Stake

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 9.6% of GRAIL, Inc.'s common stock.

Summary

• Farallon Capital Management, L.L.C. and related entities (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating their beneficial ownership of GRAIL, Inc. common stock.
• The Reporting Persons collectively beneficially own 4,161,584 shares, representing 9.6% of the class of securities.
• This ownership includes 3,590,563 shares and 571,021 shares underlying exercisable warrants.
• The filing is an amendment (Amendment No. 3) to a previous Schedule 13G filing.
• The date of the event requiring this filing is June 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on beneficial ownership changes and does not contain operational or financial performance updates.

Positives

• Farallon Capital Management, L.L.C. has a significant stake, indicating confidence or strategic interest in GRAIL, Inc.

Risks

• The exercise of warrants is subject to a Beneficial Ownership Limitation, preventing beneficial ownership exceeding 9.99% of the outstanding shares.
• The filing does not provide details on the specific investment strategy or rationale behind the ownership stake.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance or strategy.

Industry Context

StockSavvy.ai notes that significant stakes reported in Schedule 13G filings often signal active investment strategies or potential influence by institutional investors in the biotechnology and healthcare sectors, where GRAIL operates.

Stakeholder Impact

• Shareholders may view the increased stake by a significant investment manager as a positive signal, potentially indicating increased scrutiny or strategic interest in the company's performance.

Next Steps

• The Reporting Persons will continue to monitor their beneficial ownership and file amendments as required by SEC regulations.

Key Dates

Keywords

GRAIL, Farallon Capital, Schedule 13G, beneficial ownership, warrants, investment management, healthcare, biotechnology